Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

ElectroChemiLuminescence doctoral network for early sepsis diagnosis

Project description

Fast biosensors for sepsis and infection diagnosis

Hundreds of thousands of people die from sepsis and bacterial infections every year. Although early and accurate diagnosis is critical, current methods can take days to deliver results. This delay contributes to the misuse of antimicrobial drugs, fuelling the global crisis of antibiotic resistance. With the support of the Marie Skłodowska-Curie Actions programme, the ECLectic project addresses this urgent need by developing next-generation biosensors based on electrochemiluminescence. The idea is to combine this technique that generates light through electrochemical reactions with nanostructured materials and microfluidic devices. The generated point-of-care tools will dramatically reduce diagnosis time to hours.

Objective

Sepsis and bacterial infections are leading causes of death in hospitals with more than 500 thousand casualties yearly. The early infection diagnosis as well as early microbial treatment are of great importance. However, effective treatment is hampered by misuse of antimicrobial drugs, leading to resistant bacterial pathogens, high risks of infection recurrence and patient mortality as well as increased medical costs. Thus, there is a need for fast and reliable sensors systems for diagnosis of sepsis reducing the time-to-report from several days or weeks to hours, facilitating the early delivery of appropriate anti- bacteria therapy.
ECLectic network will address the worldwide problem of sepsis and bacterial infection by developing the next generation of sensing platforms, providing entirely new diagnostic paradigms. ECLectic will develop, optimize, and assess novel biosensors based on electrochemiluminescence by combining different nano- and microstructured materials and fluidic devices. ECLectic will ultimately result in novel fast and reliable point-of-care devices with applications of bacterial infection analysis, monitoring of disease recurrence, and progression. It will close the gap between innovative research in the field of nanostructured materials and their application in biosensing technology.
ECLectic will create a Center of Excellence in Europe for the training of young researchers in the research and development of sensing platforms for bacterial infection and sepsis. By training, ECLectic will provide highly skilled European researchers for academic research in biodetection, materials, microfluidics and electrochemistry as well as for the European biosensor industry. ECLectic will generate a flexible cluster of excellent young researchers ready to tackle the European challenges in the development of novel detection platform for bacterial infection. They will be trained well to become leaders in industrial as well as academic research and development.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral Networks

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2022-DN-01

See all projects funded under this call

Coordinator

ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Net EU contribution
€ 259 437,60
Address
VIA ZAMBONI 33
40126 Bologna
Italy
Region
Nord-Est Emilia-Romagna Bologna
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (9)

Partners (9)